• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将纤维素纳米晶体掺入β-壳聚糖纳米颗粒中,以提高β-半乳糖苷酶的稳定性和体外释放。

Cellulose nanocrystals incorporated β-chitosan nanoparticles to enhance the stability and in vitro release of β-galactosidase.

机构信息

State Key Laboratory for Pollution Control, School of Environmental Science and Engineering, Tongji University, Shanghai 200092, China.

State Key Laboratory of Dairy Biotechnology, Shanghai Engineering Research Center of Dairy Biotechnology, Dairy Research Institute, Bright Dairy & Food Co., Ltd, Synergetic Innovation Center of Food Safety and Nutrition, Shanghai 200436, China.

出版信息

Food Res Int. 2020 Nov;137:109380. doi: 10.1016/j.foodres.2020.109380. Epub 2020 Jun 4.

DOI:10.1016/j.foodres.2020.109380
PMID:33233082
Abstract

Beta-galactosidase (β-gal), catalyzing the transformation of lactose to glucose and galactose, had been encapsulated in β-chitosan nanoparticles (β-CS NPs) in previous work, but they were prone to aggregation and disscociation, resulting in poor bioavailability of β-gal. Herein, we developed cellulose nanocrystals (CNC, as stabilizers and fillers) stabilized β-gal loaded low molecular weight (LMW) β-CS NPs through ionic gelation technology to enhance enzyme activity and further control in vitro release of β-gal. Results showed that particle size and Zeta potential (ZP) of CNCs stabilized β-gal loaded CS NPs were 143.20 nm and -34.70 mV under the optimal conditions, respectively. Structural analysis were employed to study the incorporation of β-gal and CNC into β-CS NPs. In vitro release study conducted at pH 4.5 and 7.4 showed that both β-gal loaded β-CS NPs and CNC stabilized ones retained the release of β-gal for over 12 h. Moreover, CNC stabilized β-gal loaded β-CS NPs retained higher β-gal activity (81.23%) than that of controls (30%) within 2 h. Therefore, it was indicated that CNC incorporated β-CS NPs could serve as non-toxic and effective carriers of β-gal for the treatment of lactose intolerance.

摘要

β-半乳糖苷酶(β-gal)能够催化乳糖转化为葡萄糖和半乳糖,先前的研究已经将其包封于β-壳聚糖纳米粒子(β-CS NPs)中,但是它们容易聚集和解离,导致β-gal 的生物利用度较差。在本研究中,我们通过离子凝胶化技术,利用纤维素纳米晶体(CNC,作为稳定剂和填充剂)稳定负载β-半乳糖酶的低分子量(LMW)β-CS NPs,以提高酶活性并进一步控制β-半乳糖酶的体外释放。结果表明,在最佳条件下,CNC 稳定的负载β-半乳糖酶的 CS NPs 的粒径和 Zeta 电位(ZP)分别为 143.20nm 和-34.70mV。结构分析用于研究β-半乳糖酶和 CNC 掺入β-CS NPs 中。在 pH 4.5 和 7.4 下进行的体外释放研究表明,负载β-半乳糖酶的 CS NPs 和 CNC 稳定的负载β-半乳糖酶的 CS NPs 均能在超过 12h 内保留β-半乳糖酶的释放。此外,在 2h 内,CNC 稳定的负载β-半乳糖酶的 CS NPs 保留了更高的β-半乳糖酶活性(81.23%),而对照(30%)则较低。因此,研究结果表明,CNC 掺入的β-CS NPs 可以作为治疗乳糖不耐受的非毒性和有效的β-半乳糖酶载体。

相似文献

1
Cellulose nanocrystals incorporated β-chitosan nanoparticles to enhance the stability and in vitro release of β-galactosidase.将纤维素纳米晶体掺入β-壳聚糖纳米颗粒中,以提高β-半乳糖苷酶的稳定性和体外释放。
Food Res Int. 2020 Nov;137:109380. doi: 10.1016/j.foodres.2020.109380. Epub 2020 Jun 4.
2
Preparation, characterization and in vitro release of β-galactosidase loaded polyelectrolyte nanoparticles.β-半乳糖苷酶载聚电解质纳米粒的制备、表征及体外释放。
Int J Biol Macromol. 2018 Aug;115:1-9. doi: 10.1016/j.ijbiomac.2018.04.030. Epub 2018 Apr 10.
3
Incorporation of lysozyme into cellulose nanocrystals stabilized β-chitosan nanoparticles with enhanced antibacterial activity.溶菌酶整合到稳定的β-壳聚糖纳米粒子的纤维素纳米晶体中,增强了抗菌活性。
Carbohydr Polym. 2020 May 15;236:115974. doi: 10.1016/j.carbpol.2020.115974. Epub 2020 Feb 11.
4
Enhanced antibacterial activity of lysozyme loaded quaternary ammonium chitosan nanoparticles functionalized with cellulose nanocrystals.载溶菌酶的季铵化壳聚糖纳米粒经纤维素纳米晶功能化后增强了其抗菌活性。
Int J Biol Macromol. 2021 Nov 30;191:71-78. doi: 10.1016/j.ijbiomac.2021.09.027. Epub 2021 Sep 14.
5
Plasmid DNA-loaded chitosan/TPP nanoparticles for topical gene delivery.壳聚糖/TPP 纳米粒载质体基因传递系统的构建及其体内评价
Drug Deliv. 2011 Apr;18(3):215-22. doi: 10.3109/10717544.2010.544688. Epub 2011 Jan 12.
6
Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.载利培酮壳聚糖纳米粒的鼻腔给药制剂及生物药剂学评价。
Drug Dev Ind Pharm. 2019 Aug;45(8):1342-1350. doi: 10.1080/03639045.2019.1619759. Epub 2019 Jun 3.
7
Preparation, characterization and evaluation of antibacterial activity of catechins and catechins-Zn complex loaded β-chitosan nanoparticles of different particle sizes.不同粒径的儿茶素和儿茶素-Zn 配合物负载β-壳聚糖纳米粒子的制备、表征及抗菌活性评价。
Carbohydr Polym. 2016 Feb 10;137:82-91. doi: 10.1016/j.carbpol.2015.10.036. Epub 2015 Oct 22.
8
Enhanced antibacterial activity of uniform and stable chitosan nanoparticles containing metronidazole against anaerobic bacterium of Bacteroides fragilis.载甲硝唑的均匀稳定壳聚糖纳米粒增强抗脆弱拟杆菌的抗菌活性。
Colloids Surf B Biointerfaces. 2021 Jun;202:111691. doi: 10.1016/j.colsurfb.2021.111691. Epub 2021 Mar 13.
9
The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.负载紫杉醇/二甲基-β-环糊精包合物的壳聚糖纳米粒的制备、表征及药代动力学研究
Int J Nanomedicine. 2015 Jul 3;10:4309-19. doi: 10.2147/IJN.S83508. eCollection 2015.
10
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.